jeanny aragon-ching, md, summarize the ev103 study investigating enfortumab pembrolizumab
Published 4 years ago • 99 plays • Length 1:14
Download video MP4
Download video MP3
Similar videos
-
3:34
jeanny b. aragon-ching, md, facp, provides perspective on checkmate-274
-
4:12
jeanny b. aragon-ching, md, facp, elaborates on the imvigor130 trial
-
1:42
jeanny b. aragon-ching, md, facp, offers opinion on the role of chemotherapy in mcrpc
-
1:13
jeanny aragon-ching, md, on next generation imaging and its impact on prostate cancer treatment
-
3:18
jeanny b. aragon-ching, md, facp, regarding the checkmate-9er trial presented at gu 2021
-
1:09
david quinn, md summarizes the ev103 clinical study presented at asco gu 2020
-
0:31
jeanny b. aragon-ching, md, facp, shares how checkpoint inhibitors fit into rcc treatment algorithms
-
1:12
jeanny b. aragon-ching, md, facp, discusses new guidelines in treatment of metastatic bladder cancer
-
3:23
episode 1: introduction to this podcast series
-
2:25
efficacy of varnimcabtagene autoleucel in patients with r/r bcl with no indication for car-t therapy
-
4:46
the future of bladder cancer research
-
0:48
jeanny b. aragon-ching, md, facp, on response rates for erdafitinib in metastatic bladder cancer
-
1:18
the importance of lymphodepletion, an undervalued component of the car-t therapy cycle
-
1:15
janani s. reisenauer, m.d.: thoracic surgeon – mayo clinic
-
1:11
distinkt trial analysis: efficacy and safety of imc-001 for r/r enktl
-
1:21
jeanny b. aragon-ching, md, facp, on molecular markers in high-risk muscle-invasive bladder cancer
-
2:04
unmet need in bladder cancer
-
0:44
the clinical meaning of mrd below the threshold of mcr in aml
-
1:19
the potential of caplacizumab in the treatment of attp
-
1:07
immunotherapy in gynecological cancers
-
0:56
controversies and uncertainties in axillary management
-
0:41
unmet clinical needs for muscle-invasive bladder cancer
Clip.africa.com - Privacy-policy